NEO

Neogenomics
NASDAQ

实时行情|Nasdaq Last Sale

27.03
+0.75
+2.85%
已收盘, 17:57 04/02 EDT
开盘
25.94
昨收
26.28
最高
27.15
最低
25.79
成交量
52.40万
成交额
--
52周最高
34.97
52周最低
18.52
市值
28.34亿
市盈率(TTM)
370.27
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测NEO价格均价为33.00,最高价位38.00,最低价为30.00。

EPS

NEO 新闻

更多
  • NeoGenomics Schedules its First Quarter Earnings Release for April 28, 2020
  • ACCESSWIRE · 1天前
  • Hedge Funds Were Dumping NeoGenomics, Inc. (NEO) Before The Coronavirus
  • Insider Monkey · 4天前
  • How Does NeoGenomics, Inc.'s (NASDAQ:NEO) Earnings Growth Stack Up Against Industry Performance?
  • Simply Wall St. · 6天前
  • Healthcare In A Bear Market
  • Seeking Alpha - Article · 03/19 17:21

所属板块

医疗设施与服务
-1.30%
医疗保健提供商与服务
-0.27%

热门股票

代码
价格
涨跌幅

NEO 简况

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Houston, Texas and Nashville, and Tennessee. It offers testing services, which include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Immunohistochemistry (IHC), Molecular testing and Pathology consultation. Its Pharma Services and Clinical Trials group provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.
展开

微牛提供NeoGenomics, Inc.(NASDAQ-NEO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NEO股票新闻,以帮助您做出投资决策。